By Stu Hutson

“The worlds of academia and market economics don’t have to clash,” Gary Lubin says. But he quickly adds that, in the field of clinical trials, he’ll have to prove that in the face of conflicting evidence. (Click here to continue reading)

Image: Istock Photo